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pic drugs considered inappropriate based on an excessive
dosage or excessive duration of therapy were not exam-
ined due to the limitations of the data source. National
visit estimates were derived based on the patient sampling
weight provided for the NAMCS.
RESULTS: Approximately 2.03 million (95%CI, 1.70-
2.36 million) visits by the elderly involved potentially in-
appropriate psychotropic medications. Only two poten-
tially inappropriate psychotropic medications, secobar-
bital and pentobarbital, were not prescribed for the
elderly by office-based physicians. The remaining five po-
tentially inappropriate medications accounted for
16.85% of the visits involving psychotropic medications,
with amitriptyline alone accounting for over 10%. The
most frequently prescribed potentially inappropriate psy-
chotropic classes were antidepressants and antianxiety
agents. The logistic analysis results revealed that patient
characteristics (injury visit), drug characteristics (number
of medications and drug classes), and physician charac-
teristics (specialty and region) predict potentially inap-
propriate psychotropic prescribing.
CONCLUSION: The psychotropic prescribing patterns
in ambulatory settings raise concerns regarding the qual-
ity of care for the elderly with psychiatric illnesses. The
predictive factors may be used to design effective educa-
tional and regulatory strategies to improve prescribing
for the elderly.
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The EuroQoL EQ-5D and MOS SF-36 are two generic
quality of life measures that differ significantly in their
design (the former being an index and the latter a profile).
Both have been extensively used in evaluating interven-
tions in acute disease. This study tested their comparative
performance in a survey of patients with relapsing-remit-
ting multiple sclerosis (MS).
METHODS: 309 patients with diagnosed relapsing-
remitting MS were identified through the records of 5
specialist centers in North West England. Patients were
contacted by telephone by a specialist MS nurse and
asked to complete a set of questionnaires distributed by
mail. The questionnaire booklet reproduced the English
version of SF-36, together with the EQ-5D and a self-
completion form of the Barthel. Minimal additional
background information was obtained from all respon-
dents; 4 weeks following their completion of the initial
booklet, a second identical booklet was sent to the first
200 initial respondents. Patients in this re-test sub-group
were asked whether their health status had improved, de-
teriorated, or remained unchanged over the intervening
period.
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RESULTS: Of the 200 patients in the test/re-test sub-
group, 144 (72%) replied on both occasions. Paired
t-tests for the PCS, MCS, and general health perception
scores on the SF-36 failed to generate comprehensive evi-
dence of reliability. The weighted index form of the EQ-5D
and the visual analogue scale self-ratings provided supe-
rior evidence of reliability. Standardized response means
for both measures confirmed this general pattern.
CONCLUSION: EQ-5D performs satisfactorily as a ge-
neric measure of health-related quality of life in patients
with MS.
MHCS
THE EuroQol IN PARKINSON'S DISEASE
RESEARCH: RATED CURRENT HEALTH VS.
POPULATION·DERIVED HEALTH STATE
PREfERENCES
Chrischilles EA, Rubenstein LM, Voelker MD
Department of Preventive Medicine and Environmental Health,
University of Iowa, Iowa City, lA, USA
Policy analysts summarize health-related quality of life
(HRQL) with a single value representing the "worth of
life" arising from the many dimensions of HRQL.
OBJECTIVES: To (1) examine construct validity of two
summary HRQL measures, a visual analogue scale (VAS)
and EuroQol preference weights (PW), in Parkinson's dis-
ease (PD) patients and (2) predict PW and VAS scores
from a HRQL profile measure.
METHODS: A cross-sectional survey of 193 neurology
questionnaires contained the Medical Outcomes Study
36-item short form (SF-36), PD stage and symptoms,
VAS, EuroQol, and health satisfaction. A priori hypothe-
ses for testing construct validity predicted varying
strengths of relationships between the summary HRQL
scores and the SF-36, clinical, and health satisfaction
scores.
RESULTS: The correlation between VAS and PW was
moderate (Spearman correlation 0.415). The PW had
more ceiling scores than the VAS (19% vs. 2%). The
ranked order of correlation between the individual SF36
scale scores, the clinical scores, and the VAS was as hy-
pothesized, but that for the PW was not. Specifically, the
General Health scale ranked 1 for the VAS but 7 for the
PW; Health Satisfaction ranked 4 for the VAS but 13 for
the PW. The VAS distinguished mild from moderate stage
subjects while the PW did not. Models predicting VAS
and PW scores from SF-36 scores had adjusted model
R-squares of 0.44 (VAS) and 0.52 (PW).
CONCLUSION: The VAS, but not the PW, distinguished
subjects with different disease severity. The two measures
were only moderately correlated and had very different
relationships with the domains of HRQL, particularly
general health perceptions and health satisfaction.
